| Original language | English |
|---|---|
| Pages (from-to) | 2284-2285 |
| Number of pages | 2 |
| Journal | Journal of Allergy and Clinical Immunology: In Practice |
| Volume | 7 |
| Issue number | 7 |
| DOIs | |
| State | Published - Sep 1 2019 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Is Your Patient with Uncontrolled Severe Asthma Not Responding to a Biologic? / Samant, Maanasi; Castro, Mario.
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, No. 7, 01.09.2019, p. 2284-2285.Research output: Contribution to journal › Editorial
TY - JOUR
T1 - Is Your Patient with Uncontrolled Severe Asthma Not Responding to a Biologic?
AU - Samant, Maanasi
AU - Castro, Mario
N1 - Funding Information: Conflicts of interest: M. Samant declares no relevant conflicts of interest. M. Castro has received speaker/consultancy fees from Genentech, Pulmatrix, VIDA; has received research support and speaker/consultancy fees from Sanofi-aventis , Regeneron , AstraZeneca , Boeringer Ingelheim , Teva , and GlaxoSmithKline ; receives royalties from Elsevier; and has received research support from Chiesi , Gossamer , Novartis , the National Institutes of Health , the American Lung Association , and Patient-Centered Outcomes Research Institute . Funding Information: Conflicts of interest: M. Samant declares no relevant conflicts of interest. M. Castro has received speaker/consultancy fees from Genentech, Pulmatrix, VIDA; has received research support and speaker/consultancy fees from Sanofi-aventis, Regeneron, AstraZeneca, Boeringer Ingelheim, Teva, and GlaxoSmithKline; receives royalties from Elsevier; and has received research support from Chiesi, Gossamer, Novartis, the National Institutes of Health, the American Lung Association, and Patient-Centered Outcomes Research Institute. Conflicts of interest: M. Samant declares no relevant conflicts of interest. M. Castro has received speaker/consultancy fees from Genentech, Pulmatrix, VIDA; has received research support and speaker/consultancy fees from Sanofi-aventis, Regeneron, AstraZeneca, Boeringer Ingelheim, Teva, and GlaxoSmithKline; receives royalties from Elsevier; and has received research support from Chiesi, Gossamer, Novartis, the National Institutes of Health, the American Lung Association, and Patient-Centered Outcomes Research Institute.
PY - 2019/9/1
Y1 - 2019/9/1
UR - http://www.scopus.com/inward/record.url?scp=85067189523&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2019.05.021
DO - 10.1016/j.jaip.2019.05.021
M3 - Editorial
C2 - 31495431
AN - SCOPUS:85067189523
SN - 2213-2198
VL - 7
SP - 2284
EP - 2285
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 7
ER -